Clinical Trials Browser

Aspirin × Clear all

NCT02965703 2026-03-18

Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma

Phase 2 Active not recruiting

81 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms

NCT02647099 2026-03-13

ALASCCA

Phase 3 Active not recruiting

626 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Phase 4 Not yet recruiting

Endometrial Neoplasms

NCT05036109 2026-02-10

DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease

Phase NA Completed

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT06728072 2026-02-09

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04184921 2026-02-03

Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT03480776 2026-01-14

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

Phase 2 Active not recruiting

Ovarian Cancer Prevention

NCT05080946 2026-01-08

Using Aspirin to Improve Immunological Features of Ovarian Tumors

Phase EARLY_PHASE1 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05557877 2026-01-06

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT03079999 2025-12-18

Study of Aspirin in Patients With Vestibular Schwannoma

Phase 2 Active not recruiting

Neuroma, Acoustic, Neurofibromatosis 2

NCT04188119 2025-12-08

IMpALA

Phase 2 Withdrawn

Breast Neoplasms

NCT05411718 2025-11-13

A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms

NCT02521285 2025-10-23

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

Phase 2 Active not recruiting

21 enrolled 35 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Phase 4 Enrolling by invitation

Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

NCT04182100 2025-09-15

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

Phase 2 Completed

29 enrolled 15 charts

Myeloproliferative Disorders, Polycythemia Vera

NCT03899987 2025-08-27

Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT04379999 2025-08-07

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Phase EARLY_PHASE1 Completed

Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis

NCT03326791 2025-07-31

ASAC

Phase 2/3 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06290765 2025-07-31

PV

Phase 4 Not yet recruiting

Myeloproliferative Disorders, Polycythemia Vera

NCT03805932 2025-07-24

Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia

Phase 1 Active not recruiting

18 enrolled 15 charts

Other hematologic neoplasm

Leukemia, Hairy Cell

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Phase 3 Not yet recruiting

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT03819101 2025-06-26

PEACE-4

Phase 3 Recruiting

Prostatic Neoplasms

NCT02804815 2025-06-10

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

Phase 3 Active not recruiting

11,000 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Neoplasms, Prostatic Neoplasms, Recurrence, Colorectal Neoplasms

NCT02467582 2025-05-16

Adjuvant Aspirin Treatment for Colon Cancer Patients

Phase 3 Terminated

1,040 enrolled 11 charts

Gastrointestinal

Colonic Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT00357682 2025-05-01

AspECT

Phase 3 Completed

2,557 enrolled 17 charts

GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

NCT05158374 2025-02-06

Molecular Effects of Aspirin & Metformin on Colonic Epithelium

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT03245489 2025-01-31

Anti-platelet + Pembro for H&N Tumors

Phase 1 Completed

Head and Neck Neoplasms

NCT04160546 2024-12-31

ResToP

Phase 2 Active not recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT04214990 2024-12-27

EASTERN

Phase 3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT04534218 2024-12-20

REPROGRAM-01

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis

NCT05462613 2024-12-20

REPROGRAM-02

Phase 2/3 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT00482261 2024-11-08

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Phase 2 Completed

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT06002490 2024-11-08

A Study to Evaluate P1101 in Japanese PV Patients

Phase 3 Completed

Myeloproliferative Disorders, Polycythemia Vera

NCT03378297 2024-10-30

IMPACT

Phase EARLY_PHASE1 Completed

Ovarian Neoplasms

NCT03003325 2024-09-19

Low-PV

Phase 2 Completed

Polycythemia Vera

NCT05507645 2024-09-05

PUMICE

Phase 3 Completed

Ischemic Stroke, Lymphoma, Follicular, Thrombosis

NCT05865548 2024-08-13

Addition of Aspirin to Standard of Care in Oral Cancer

Phase 2/3 Completed

Mouth Neoplasms

NCT04243122 2024-05-29

AIRPORT-MPN

Phase 2 Completed

Classical hematologyMyeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT03464305 2024-03-19

ASPIRIN

Phase 3 Active not recruiting

Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Pathologic Processes, Recurrence, Colorectal Neoplasms, Disease Attributes

NCT02301286 2024-03-18

ASPIRIN

Phase 3 Active not recruiting

Gastrointestinal

Colonic Neoplasms

NCT04245644 2024-03-12

CAOS

Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03654105 2024-03-07

SMILE

Phase 2 Active not recruiting

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT03728179 2024-02-20

RACIN

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT00565708 2024-02-02

ASCOLT

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02834403 2023-12-15

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Phase 1/2 Completed

37 enrolled 20 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05637567 2023-11-13

ASAP

Phase 2 Not yet recruiting

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT00578721 2023-07-07

Trial of Aspirin and Arginine Restriction in Colorectal Cancer

Phase 2 Completed

24 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms

NCT02927249 2023-04-05

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Phase 3 Terminated

3,021 enrolled 9 charts

Node Positive HER2 Negative Breast Cancer

NCT03103152 2023-03-29

PROVENT

Phase 2/3 Completed

104 enrolled 14 charts

Prostatic Neoplasms

NCT02659384 2023-03-14

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms